- Home
- PECO vs ACLX Comparison
PECO vs ACLX Comparison
Compare PECO & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PECO
- ACLX
- Stock Information
- Founded
- PECO 1991
- ACLX 2015
- Country
- PECO United States
- ACLX United States
- Employees
- PECO N/A
- ACLX N/A
- Industry
- PECO Real Estate Investment Trusts
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- PECO Real Estate
- ACLX Health Care
- Exchange
- PECO Nasdaq
- ACLX Nasdaq
- Market Cap
- PECO 4.2B
- ACLX 4.4B
- IPO Year
- PECO 2021
- ACLX 2022
- Fundamental
- Price
- PECO $34.40
- ACLX $87.05
- Analyst Decision
- PECO Buy
- ACLX Strong Buy
- Analyst Count
- PECO 6
- ACLX 14
- Target Price
- PECO $38.20
- ACLX $113.86
- AVG Volume (30 Days)
- PECO 928.4K
- ACLX 556.9K
- Earning Date
- PECO 10-23-2025
- ACLX 11-06-2025
- Dividend Yield
- PECO 3.63%
- ACLX N/A
- EPS Growth
- PECO 13.92
- ACLX N/A
- EPS
- PECO 0.55
- ACLX N/A
- Revenue
- PECO $694,639,000.00
- ACLX $56,979,000.00
- Revenue This Year
- PECO $9.97
- ACLX N/A
- Revenue Next Year
- PECO $5.40
- ACLX $210.73
- P/E Ratio
- PECO $61.40
- ACLX N/A
- Revenue Growth
- PECO 10.31
- ACLX N/A
- 52 Week Low
- PECO $32.40
- ACLX $47.86
- 52 Week High
- PECO $40.12
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- PECO 52.29
- ACLX 60.41
- Support Level
- PECO $32.98
- ACLX $84.60
- Resistance Level
- PECO $34.08
- ACLX $94.07
- Average True Range (ATR)
- PECO 0.48
- ACLX 3.81
- MACD
- PECO 0.06
- ACLX 0.10
- Stochastic Oscillator
- PECO 86.75
- ACLX 53.86
About PECO Phillips Edison & Company Inc.
Phillips Edison & Co Inc is a real estate investment trust. The company also operates a third-party investment management business providing property management and advisory services to four unconsolidated institutional joint ventures, in which it has a partial ownership interests, and one private fund. It invests in well-occupied, grocery-anchored neighborhood and community shopping centers. It holds an integrated in-house operating platform built on market of expertise designed to optimize property value and consistently deliver a great shopping experience.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.